None
DE
Verrica Pharmaceuticals (NASDAQ:VRCA) Releases Earnings Results, Misses Estimates By $0.07 EPS
['Max Byerly']
Ticker Report
Verrica Pharmaceuticals (NASDAQ:VRCA – Get Free Report) announced its quarterly earnings data on Thursday.
Verrica Pharmaceuticals Stock Down 5.2%NASDAQ:VRCA traded down $0.28 during trading hours on Friday, reaching $5.08.
Verrica Pharmaceuticals has a one year low of $3.28 and a one year high of $9.82.
HC Wainwright initiated coverage on Verrica Pharmaceuticals in a report on Tuesday, May 26th.
Featured StoriesReceive News & Ratings for Verrica Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verrica Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.